早产儿视网膜病变抗VEGF治疗后持续性周边无血管视网膜预后与治疗策略的研究方案
本研究为前瞻性研究,纳入接受抗VEGF玻璃体腔注射且未接受激光治疗的早产儿视网膜病变(ROP)患者,按荧光素眼底血管造影(FFA)结果分为渗漏组与非渗漏组;渗漏组随机分为激光组与非激光组,比较预后。旨在探究持续性周边无血管视网膜的不良预后发生率、血管渗漏与不良预后的关系,以及预防性周边光凝的必要性。
要点
- 抗VEGF治疗后持续性周边无血管视网膜的不良预后需前瞻性评估。
- FFA血管渗漏与视网膜裂孔、脱离等不良预后的关系尚不明确。
- 预防性周边光凝的必要性需随机对照研究提供证据。
核心结论
- 研究旨在明确ROP抗VEGF治疗后持续性周边无血管视网膜的不良预后发生率及预防性光凝的必要性。
研究设计与样本
- 前瞻性研究,纳入接受抗VEGF玻璃体腔注射且未接受激光治疗的ROP患者。
- 所有眼按FFA血管渗漏程度分为渗漏组与非渗漏组,渗漏组随机分为激光组与非激光组。
- 非渗漏组与非激光组(有渗漏)进行队列研究(观察性),渗漏组进行随机对照研究(实验性)。
关键数值与推荐
- 主要观察指标包括病变再激活、视网膜裂孔和视网膜脱离的发生率。
- 评估FFA血管渗漏与上述病理改变的关系。
- 比较渗漏组中激光组与非激光组的预后差异。
临床怎么用
- 为ROP抗VEGF治疗后持续性周边无血管视网膜的治疗策略提供证据。
- 为预防性周边光凝的适应证提供依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prophylactic peripheral photocoagulation has been proposed to be applied to persistent, peripheral, avascular retina for retinopathy of prematurity (ROP) patients who have received an intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) agents. However, there are doubts regarding the necessity of this prophylactic action regardless of fundus fluorescein angiography (FFA) results. The adverse prognosis for persistent avascular retina after anti-VEGF therapy in ROP patients is not well understood. The relationship between vascular leakage and an adverse prognosis is also unknown. Therefore, it would be of value to study the above issues to shape the treatment strategy of persistent avascular retina after intravitreal anti-VEGF therapy in ROP patients. METHODS/DESIGN: This is a prospective study of ROP patients with persistent avascular retina who have received anti-VEGF intravitreal therapy and have never received laser therapy. All the eyes being studied will be followed up and examined by FFA after anti-VEGF treatment and categorized into two groups, a leakage group and a non-leakage group according to the extent of vascular leakage from FFA results. The eyes being studied in the leakage group will be further randomized into two groups, a laser group and a non-laser group. A cohort study (observational) will be conducted on the non-leakage group and the non-laser group (with leakage) to investigate the incidence of an adverse prognosis for reactivation, retinal tear and retinal detachment; as well as to investigate the relationship between vascular leakage from FFA results and the abovementioned pathological changes. A randomized controlled study (experimental) will be conducted on the leakage group to compare the prognosis between the laser group and the non-laser group. DISCUSSION: The present study aims to investigate the occurrence rates of an adverse prognosis including reactivation, retinal tear and retinal detachment after anti-VEGF therapy in ROP patients with persistent avascular retina; to assess the relationship between vascular leakage from FFA results and the abovementioned pathological changes; to compare the prognosis of persistent avascular retina with or without prophylactic peripheral photocoagulation in these patients; to shape the treatment strategy and provide evidence for the indications of prophylactic photocoagulation. TRIAL REGISTRATION: Chinese Clinical Trial Registry (ChiCTR), ID: ChiCTR-ROC-17013253. Registered on 5 November 2017. http://www.chictr.org.cn/showproj.aspx?proj=22703.
引用
- Yu Y, Wang J, Chen F, et al. Study protocol for prognosis and treatment strategy of peripheral persistent avascular retina after intravitreal anti-VEGF therapy in retinopathy of prematurity. Trials. 2020. PMID: 32513245. doi:10.1186/s13063-020-04371-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。